SCHEMBL18753484

SCHEMBL18753484

Cc1cc(C(=O)N2CCN(C(=O)c3cncc(F)c3)CC2)ccc1N[SH](=O)=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MYC P01106 2/20 0.54
▸ HPGD P15428 2/20 0.43
▸ ABL1 P00519 2/20 0.41
▸ BCR P11274 2/20 0.41
▸ LMNA P02545 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ KMT2A Q03164 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ ALDH1A1 P00352 4/20 0.39
▸ GAA P10253 1/20 0.39
▸ LRRK2 Q5S007 2/20 0.39
▸ TSHR P16473 1/20 0.39
▸ TP53 P04637 1/20 0.38
▸ CCNA2 P20248 1/20 0.38
▸ CDK2 P24941 1/20 0.38
▸ CDK7 P50613 1/20 0.38
▸ CCNH P51946 1/20 0.38
▸ MNAT1 P51948 1/20 0.38
▸ PKM P14618 1/20 0.38
▸ CCNC P24863 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18753738 0.87 PKM (0.48) MYCHPGDLMNASMN1; SMN2ALDH1A1
SCHEMBL18753869 0.86 MYC (0.49) MYCLMNAALDH1A1LRRK2
SCHEMBL18753811 0.85 PKM (0.55) MYCABL1BCRKMT2AMEN1
SCHEMBL18753307 0.83 TSHR (0.47) HPGDLMNASMN1; SMN2ALDH1A1GAA
SCHEMBL18753318 0.82 KMT2A (0.59) HPGDABL1BCRLMNASMN1; SMN2
SCHEMBL18753740 0.82 LMNA (0.48) ABL1BCRLMNASMN1; SMN2KMT2A
SCHEMBL18753852 0.82 POLB (0.45) MYCHPGDABL1BCRKMT2A
SCHEMBL18753355 0.81 ABL1 (0.46) HPGDABL1BCRLMNASMN1; SMN2
SCHEMBL18753306 0.79 GBA1 (0.44) HPGDLMNAGAA
SCHEMBL18753487 0.79 ALDH1A1 (0.54) HPGDABL1BCRLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3241554-B1 QUINOLINE-8-SULFONAMIDE DERIVATIVES HAVING AN ANTICANCER ACTIVITY AGIOS PHARMACEUTICALS INC (US) 2020-01-29 — — EP disclosed
EP-2448582-B1 QUINOLINE-8-SULFONAMIDE DERIVATIVES HAVING AN ANTICANCER ACTIVITY AGIOS PHARMACEUTICALS INC (US) 2017-04-19 — — EP disclosed
Send feedback